|
|
.
See Category: Diseases of the musculoskeletal system and connective tissue
See Header: Cervical disc disorder with myelopathy, mid-cervical region
ICD-10 (CM) Code and Descriptor
|
M50.021 |
Cervical disc disorder at C4-C5 level with myelopathy
|
M50021 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 34.76%
|
26.36%
|
15.49%
|
9.17%
|
5.65%
|
3.01%
|
1.71%
|
0.87%
|
0.80%
|
0.57%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for M50.021*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
A9270
|
NON-COVERED ITEM OR SERVICE |
1,287
|
5,849
|
|
97110
|
THERAPEUTIC EXERCISES |
781
|
1,306
|
|
97530
|
THERAPEUTIC ACTIVITIES |
673
|
1,139
|
|
J0690
|
CEFAZOLIN SODIUM INJECTION |
622
|
3,032
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
513
|
4,696
|
|
C1713
|
ANCHOR/SCREW BN/BN,TIS/BN |
511
|
3,370
|
|
J3010
|
FENTANYL CITRATE INJECTION |
498
|
1,121
|
|
22853
|
INSJ BIOMECHANICAL DEVICE |
472
|
537
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
472
|
33,642
|
|
22551
|
ARTHRD ANT NTRBDY CERVICAL |
456
|
460
|
|
J2405
|
ONDANSETRON HCL INJECTION |
445
|
1,975
|
|
72040
|
X-RAY EXAM NECK SPINE 2-3 VW |
390
|
403
|
|
22552
|
ARTHRD ANT NTRBD CERVICAL EA |
363
|
405
|
|
J1170
|
HYDROMORPHONE INJECTION |
362
|
651
|
|
J3490
|
DRUGS UNCLASSIFIED INJECTION |
353
|
2,545
|
|
97116
|
GAIT TRAINING THERAPY |
306
|
400
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
302
|
308
|
|
J2250
|
INJ MIDAZOLAM HYDROCHLORIDE |
286
|
595
|
|
80048
|
METABOLIC PANEL TOTAL CA |
260
|
261
|
|
J7120
|
RINGERS LACTATE INFUSION |
251
|
392
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
M50.021 related to the following DRG Codes:
551-552
|
